Free Trial

Illumina (ILMN) Competitors

Illumina logo
$87.54 -0.44 (-0.50%)
Closing price 04:00 PM Eastern
Extended Trading
$87.88 +0.33 (+0.38%)
As of 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMO

Should you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Illumina vs. Its Competitors

Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking.

Illumina presently has a consensus target price of $126.94, suggesting a potential upside of 43.40%. Agilent Technologies has a consensus target price of $140.15, suggesting a potential upside of 15.95%. Given Illumina's higher probable upside, equities research analysts clearly believe Illumina is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Illumina
1 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.47
Agilent Technologies
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

Illumina has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500.

89.4% of Illumina shares are held by institutional investors. 2.6% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Illumina had 6 more articles in the media than Agilent Technologies. MarketBeat recorded 16 mentions for Illumina and 10 mentions for Agilent Technologies. Illumina's average media sentiment score of 1.42 beat Agilent Technologies' score of 1.23 indicating that Illumina is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Illumina
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Agilent Technologies
9 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Agilent Technologies has a net margin of 17.59% compared to Illumina's net margin of -27.95%. Agilent Technologies' return on equity of 25.92% beat Illumina's return on equity.

Company Net Margins Return on Equity Return on Assets
Illumina-27.95% 13.37% 5.49%
Agilent Technologies 17.59%25.92%13.24%

Illumina received 245 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.04% of users gave Agilent Technologies an outperform vote while only 65.15% of users gave Illumina an outperform vote.

CompanyUnderperformOutperform
IlluminaOutperform Votes
1116
65.15%
Underperform Votes
597
34.85%
Agilent TechnologiesOutperform Votes
871
71.04%
Underperform Votes
355
28.96%

Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Illumina$4.34B3.23-$1.22B-$6.07-14.58
Agilent Technologies$6.51B5.27$1.29B$4.0529.84

Summary

Agilent Technologies beats Illumina on 10 of the 19 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ILMN vs. The Competition

MetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$14.01B$4.61B$5.60B$8.65B
Dividend YieldN/A0.56%5.27%4.19%
P/E Ratio-11.5225.2327.3320.13
Price / Sales3.233.93412.21156.99
Price / Cash20.7236.2838.2534.64
Price / Book5.911.697.154.74
Net Income-$1.22B-$82.28M$3.23B$247.88M
7 Day Performance6.45%5.64%3.49%2.64%
1 Month Performance16.85%16.40%12.92%9.95%
1 Year Performance-21.38%-9.45%32.15%15.33%

Illumina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ILMN
Illumina
4.9128 of 5 stars
$87.54
-0.5%
$126.94
+45.0%
-19.9%$13.86B$4.34B-11.4011,500Positive News
Analyst Forecast
Options Volume
A
Agilent Technologies
4.6351 of 5 stars
$116.77
+0.8%
$140.15
+20.0%
-9.3%$33.17B$6.51B28.8317,900Positive News
MTD
Mettler-Toledo International
3.6973 of 5 stars
$1,196.53
+1.0%
$1,302.11
+8.8%
-15.6%$24.87B$3.83B29.5218,000Positive News
WAT
Waters
4.0963 of 5 stars
$348.56
-0.7%
$390.19
+11.9%
+16.1%$20.74B$2.98B32.558,200
TECH
Bio-Techne
4.868 of 5 stars
$49.88
+2.4%
$72.00
+44.3%
-33.3%$7.82B$1.21B50.383,000Analyst Downgrade
CRL
Charles River Laboratories International
4.7485 of 5 stars
$147.51
+1.9%
$171.85
+16.5%
-29.6%$7.25B$4.02B983.4321,400
BIO
Bio-Rad Laboratories
4.8016 of 5 stars
$225.84
+2.9%
$324.25
+43.6%
-19.0%$6.15B$2.54B-3.478,200Analyst Downgrade
Analyst Revision
BRKR
Bruker
4.9382 of 5 stars
$39.19
+2.3%
$56.22
+43.5%
-37.4%$5.94B$3.45B51.568,520Insider Trade
PACB
Pacific Biosciences of California
1.595 of 5 stars
$1.21
+5.7%
$2.13
+76.9%
-38.6%$361.60M$152.36M-0.73730Positive News
HBIO
Harvard Bioscience
3.8904 of 5 stars
$0.56
+36.2%
$3.00
+438.6%
-78.8%$24.63M$91.40M-1.69490Trending News
Short Interest ↑
Gap Up
High Trading Volume
TMO
Thermo Fisher Scientific
4.9806 of 5 stars
$408.57
+1.7%
$605.30
+48.2%
-28.7%$154.23B$42.90B24.72130,000Positive News

Related Companies and Tools


This page (NASDAQ:ILMN) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners